The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Anticoagulants Market Research Report 2025
Synopsis
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
The global Injectable Anticoagulants market was valued at US$ 6092 million in 2023 and is anticipated to reach US$ 7058.3 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
Market competition is intense. Sanofi, Genentech (Roche), Boehringer Ingelheim and Pfizer, etc. are the leaders of the industry, with about 68% market shares.
North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
This report aims to provide a comprehensive presentation of the global market for Injectable Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anticoagulants.
Report Scope
The Injectable Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Anticoagulants companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Segment by Type
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Others
Segment by Application
VTE
ACS/MI
AF
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anticoagulants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
The global Injectable Anticoagulants market was valued at US$ 6092 million in 2023 and is anticipated to reach US$ 7058.3 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
Market competition is intense. Sanofi, Genentech (Roche), Boehringer Ingelheim and Pfizer, etc. are the leaders of the industry, with about 68% market shares.
North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
This report aims to provide a comprehensive presentation of the global market for Injectable Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anticoagulants.
Report Scope
The Injectable Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Anticoagulants companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Segment by Type
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Others
Segment by Application
VTE
ACS/MI
AF
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anticoagulants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anticoagulants Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Low-Molecular-Weight Heparin (LMWH)
1.2.3 Direct Thrombin Inhibitor (DTI)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Injectable Anticoagulants Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Anticoagulants Market Perspective (2019-2030)
2.2 Injectable Anticoagulants Growth Trends by Region
2.2.1 Global Injectable Anticoagulants Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Injectable Anticoagulants Historic Market Size by Region (2019-2024)
2.2.3 Injectable Anticoagulants Forecasted Market Size by Region (2025-2030)
2.3 Injectable Anticoagulants Market Dynamics
2.3.1 Injectable Anticoagulants Industry Trends
2.3.2 Injectable Anticoagulants Market Drivers
2.3.3 Injectable Anticoagulants Market Challenges
2.3.4 Injectable Anticoagulants Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Anticoagulants Players by Revenue
3.1.1 Global Top Injectable Anticoagulants Players by Revenue (2019-2024)
3.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2019-2024)
3.2 Global Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Anticoagulants Revenue
3.4 Global Injectable Anticoagulants Market Concentration Ratio
3.4.1 Global Injectable Anticoagulants Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Anticoagulants Revenue in 2023
3.5 Injectable Anticoagulants Key Players Head office and Area Served
3.6 Key Players Injectable Anticoagulants Product Solution and Service
3.7 Date of Enter into Injectable Anticoagulants Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Anticoagulants Breakdown Data by Type
4.1 Global Injectable Anticoagulants Historic Market Size by Type (2019-2024)
4.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2025-2030)
5 Injectable Anticoagulants Breakdown Data by Application
5.1 Global Injectable Anticoagulants Historic Market Size by Application (2019-2024)
5.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Injectable Anticoagulants Market Size (2019-2030)
6.2 North America Injectable Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Injectable Anticoagulants Market Size by Country (2019-2024)
6.4 North America Injectable Anticoagulants Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Anticoagulants Market Size (2019-2030)
7.2 Europe Injectable Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Injectable Anticoagulants Market Size by Country (2019-2024)
7.4 Europe Injectable Anticoagulants Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Anticoagulants Market Size (2019-2030)
8.2 Asia-Pacific Injectable Anticoagulants Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Injectable Anticoagulants Market Size by Region (2019-2024)
8.4 Asia-Pacific Injectable Anticoagulants Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Anticoagulants Market Size (2019-2030)
9.2 Latin America Injectable Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Injectable Anticoagulants Market Size by Country (2019-2024)
9.4 Latin America Injectable Anticoagulants Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Anticoagulants Market Size (2019-2030)
10.2 Middle East & Africa Injectable Anticoagulants Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Injectable Anticoagulants Market Size by Country (2019-2024)
10.4 Middle East & Africa Injectable Anticoagulants Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injectable Anticoagulants Introduction
11.1.4 Sanofi Revenue in Injectable Anticoagulants Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Detail
11.2.2 Genentech (Roche) Business Overview
11.2.3 Genentech (Roche) Injectable Anticoagulants Introduction
11.2.4 Genentech (Roche) Revenue in Injectable Anticoagulants Business (2019-2024)
11.2.5 Genentech (Roche) Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction
11.3.4 Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Injectable Anticoagulants Introduction
11.4.4 Pfizer Revenue in Injectable Anticoagulants Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 The Medicines Company
11.5.1 The Medicines Company Company Detail
11.5.2 The Medicines Company Business Overview
11.5.3 The Medicines Company Injectable Anticoagulants Introduction
11.5.4 The Medicines Company Revenue in Injectable Anticoagulants Business (2019-2024)
11.5.5 The Medicines Company Recent Development
11.6 Aspen
11.6.1 Aspen Company Detail
11.6.2 Aspen Business Overview
11.6.3 Aspen Injectable Anticoagulants Introduction
11.6.4 Aspen Revenue in Injectable Anticoagulants Business (2019-2024)
11.6.5 Aspen Recent Development
11.7 Otsuka
11.7.1 Otsuka Company Detail
11.7.2 Otsuka Business Overview
11.7.3 Otsuka Injectable Anticoagulants Introduction
11.7.4 Otsuka Revenue in Injectable Anticoagulants Business (2019-2024)
11.7.5 Otsuka Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
